Cite
HARVARD Citation
Lee, K. et al. (n.d.). 725PEfficacy and safety of nab-paclitaxel plus gemcitabine (AG) vs. FOLFIRINOX (FFX) as first line chemotherapy for metastatic pancreatic cancer (mPC): Retrospective analysis. Annals of oncology. p. . [Online].